NCT00330772View on ClinicalTrials.gov

Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study

PHASE3CompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

December 31, 2008

Conditions

Coronary Artery DiseaseCoronary Artery Bypass Grafting

Interventions

DRUG

Aspirin

DRUG

Clopidogrel

Trial Locations (1)

L8L 2X2

Hamilton General Hospital, Hamilton

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Hamilton Health Sciences Corporation

OTHER

NCT00330772 - Preoperative Aspirin and Postoperative Antiplatelets in Coronary Artery Bypass Grafting: The PAPA CABG Study | Biotech Hunter | Biotech Hunter